Yatırımcı.AI

ECILC vs LILAK Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and LILAK side by side.

ECILCLILAK
StockFund

If You Had Invested TRY 10,000

Metric Comparison

ECILC vs LILAK Comparison
MetricECILCLILAKSector median
Last price (TL)63.6024.0618.72
Daily change−7.15%−4.52%−6.22%
Market capTRY 43.6BTRY 14.2BTRY 4.3B
P/E—13.4017.35
P/B0.680.801.09
Dividend yield2.04%4.33%0.90%
Return on equity−3.08%6.56%1.78%
Free float22.02%16.96%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the ECILC vs LILAK Comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and LILAK (Lila Kağıt) side by side as of Sep 28, 2026, 14:19. Of the 16 metrics compared, ECILC leads in 5 and LILAK leads in 11.

Highlights: Daily change: LILAK leads (−4.52% vs −7.15%). Market cap: ECILC leads (TRY 43.6B vs TRY 14.2B). P/B: ECILC leads (0.68 vs 0.80). EV/EBITDA: LILAK leads (4.16 vs 165.19). EV/Sales: LILAK leads (1.30 vs 9.35). Dividend yield: LILAK leads (4.33% vs 2.04%). Gross margin: ECILC leads (37.83% vs 30.03%). EBITDA margin (annual): LILAK leads (24.04% vs 11.49%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs 13.40); by P/B, ECILC trades at the lower multiple (0.68 vs 0.80).

Annual net margin is −20.86% for ECILC and 8.96% for LILAK; return on equity is −3.08% for ECILC and 6.56% for LILAK.

The leverage ratio is 18.92 for ECILC and 25.49 for LILAK; net debt/EBITDA is 1.37 for ECILC and −1.83 for LILAK. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.